Opportunity Information: Apply for RFI 720617 22 002

USAID Uganda released this notice as a Request for Information (RFI) about a planned, integrated health funding activity tentatively called the "Uganda Health Activity." The main purpose is to alert organizations that USAID is designing a new health program and to gather written feedback on the draft program description and proposed key personnel requirements (referenced as an attachment in the RFI). It is not an application solicitation and it is not a promise that a future award will be made. Instead, it is a market-sounding and design step meant to improve the eventual activity structure before USAID decides whether to publish a formal Notice of Funding Opportunity (NOFO).

Programmatically, the activity is framed around improving health outcomes in priority districts by increasing access to and use of quality services and by boosting health system performance at subnational levels. The draft results USAID highlights are threefold. First, it aims to expand and improve service delivery at both facility and community levels across several linked areas: maternal, newborn, and child health (MNCH); family planning and broader reproductive health (FP/RH); nutrition; and water, sanitation, and hygiene coupled with infection prevention and control (WASH/IPC). Second, it intends to strengthen local ownership and leadership so improvements can be sustained, which signals a focus on building the capabilities of Ugandan institutions and leaders rather than relying indefinitely on external technical assistance. Third, it seeks to strengthen health system resilience at regional, district, and community levels, suggesting attention to the systems that keep services functioning under stress (for example, management, coordination, and the ability to adapt to shocks).

A notable feature is that the activity is also expected to strengthen the capacity of local PEPFAR implementing partners to lead and sustain the epidemic response as part of broader sustainability efforts. In practical terms, that points to closer alignment between general health system strengthening and HIV epidemic-control capacity, with an emphasis on transitioning leadership and implementation responsibilities to local entities over time.

From a funding and administrative standpoint, the listing identifies USAID Kampala as the issuing office, with the anticipated instrument type noted as a cooperative agreement and the activity category as Health (CFDA/assistance listing 98.001). Eligibility is described as unrestricted, meaning USAID is not limiting who can provide feedback at the RFI stage, and later competition rules (if a NOFO is released) would be defined in that formal announcement. The posting includes no award ceiling and does not specify an expected number of awards, which is consistent with an RFI where funding specifics may not be finalized. The opportunity number is RFI 720617 22 002, with a creation date of 2021-12-13 and an original closing date for RFI responses of 2022-01-24.

The RFI includes several standard caveats that matter for interested organizations. USAID emphasizes that the RFI is for planning only, does not commit the agency to issue a NOFO or make an award, and that any costs incurred responding are the respondent's responsibility. Responding does not provide any competitive advantage (and does not exclude anyone) for any future NOFO. If USAID does move forward, the formal funding announcement would be posted on grants.gov and/or sam.gov, and organizations are expected to monitor those sites themselves.

Operationally, feedback had to be submitted by email to kampalausaidsolicita@usaid.gov by the stated deadline, and organizations were told not to submit applications at this time. USAID also notes that information submitted becomes USAID property, so sensitive or non-shareable information should not be included. Respondents should not expect individualized feedback; USAID will use submissions to refine the activity design and may revise the concept based on what it receives, but is not required to make changes. Overall, the RFI is essentially an early design consultation for a multi-component, district-focused health systems and service delivery activity intended to advance Government of Uganda health policy objectives while building durable local leadership and resilience.

  • The Uganda USAID-Kampala in the health sector is offering a public funding opportunity titled "USAID/Uganda Health Activity" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
  • This funding opportunity was created on 2021-12-13.
  • Applicants must submit their applications by 2022-01-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Unrestricted.
Apply for RFI 720617 22 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs): USAID Uganda "Uganda Health Activity" Request for Information (RFI)

1) What is this notice from USAID Uganda?

This notice is a Request for Information (RFI) issued by USAID Uganda about a planned, integrated health funding activity tentatively called the "Uganda Health Activity." The RFI is being used to alert organizations that USAID is designing a new health program and to collect written feedback to help refine the activity before any formal funding opportunity is released.

2) Is this an application or a funding solicitation?

No. This RFI is not an application solicitation, and organizations were specifically told not to submit applications at this time. It is a planning and market-sounding step intended to gather feedback on USAID's draft program description and proposed key personnel requirements (referenced in an attachment to the RFI).

3) Does the RFI guarantee that USAID will release a future Notice of Funding Opportunity (NOFO) or make an award?

No. USAID states that the RFI does not commit the agency to issue a NOFO and does not promise that a future award will be made. USAID may decide whether or not to proceed with a formal competition after considering internal priorities and any information received through the RFI process.

4) What is the tentative name of the planned program?

The planned activity is tentatively called the "Uganda Health Activity."

5) What is USAID trying to achieve through the planned Uganda Health Activity?

The activity is framed around improving health outcomes in priority districts by increasing access to and use of quality services and by improving health system performance at subnational levels (regional, district, and community).

6) What are the draft results areas USAID highlights for this activity?

USAID highlights three draft results areas:

  • Expand and improve service delivery at facility and community levels across linked technical areas (including MNCH, FP/RH, nutrition, and WASH/IPC).
  • Strengthen local ownership and leadership so improvements can be sustained over time.
  • Strengthen health system resilience at regional, district, and community levels.

7) What technical areas are included in the planned service delivery focus?

The RFI describes service delivery improvements at both facility and community levels across:

  • Maternal, newborn, and child health (MNCH)
  • Family planning and broader reproductive health (FP/RH)
  • Nutrition
  • Water, sanitation, and hygiene with infection prevention and control (WASH/IPC)

8) What does "strengthen local ownership and leadership" imply in this RFI?

Based on the RFI description, it signals an emphasis on building the capabilities of Ugandan institutions and leaders so that improvements can continue without relying indefinitely on external technical assistance.

9) What does "health system resilience" mean in the context of this planned activity?

The RFI indicates attention to the systems that keep services functioning under stress at regional, district, and community levels. This can include elements like management, coordination, and the ability to adapt to shocks, as implied by the RFI narrative.

10) How does PEPFAR relate to this planned USAID health activity?

The RFI states that the activity is expected to strengthen the capacity of local PEPFAR implementing partners to lead and sustain the epidemic response as part of broader sustainability efforts. This suggests alignment between broader health system strengthening and sustaining HIV epidemic-control capacity, with an emphasis on transitioning leadership and implementation responsibilities to local entities over time.

11) Who is the issuing office for this RFI?

The issuing office identified in the listing is USAID Kampala.

12) What type of award instrument is anticipated (if USAID proceeds to a formal opportunity later)?

The listing notes an anticipated instrument type of a cooperative agreement.

13) What is the activity category and assistance listing number?

The activity category is Health, and the CFDA/assistance listing number shown is 98.001.

14) Who was eligible to respond to the RFI?

Eligibility for providing feedback at the RFI stage is described as unrestricted, meaning USAID was not limiting who could submit a response to the RFI.

15) Does responding to the RFI provide any competitive advantage for a future NOFO?

No. USAID states that responding does not provide any competitive advantage and also does not exclude anyone from competing in any future NOFO (if one is issued).

16) Are funding details like award ceiling or number of awards available in this RFI?

No. The posting includes no award ceiling and does not specify an expected number of awards. This is consistent with an RFI stage where funding specifics may not be finalized.

17) What is the opportunity number for this RFI?

The opportunity number is RFI 720617 22 002.

18) What were the creation date and the original closing date for RFI responses?

The creation date is 2021-12-13, and the original closing date for RFI responses was 2022-01-24.

19) How were RFI responses supposed to be submitted?

Feedback had to be submitted by email to kampalausaidsolicita@usaid.gov by the stated deadline.

20) Should organizations send proposals or applications in response to this RFI?

No. Organizations were told not to submit applications at this time. The RFI is only for written feedback on the draft program description and proposed key personnel requirements.

21) Where would USAID post a future formal funding opportunity (NOFO) if it decides to move forward?

USAID indicates that any formal funding announcement would be posted on grants.gov and/or sam.gov, and organizations are expected to monitor those sites themselves.

22) Will USAID provide individualized feedback to RFI respondents?

No. USAID notes that respondents should not expect individualized feedback. Submissions are intended to inform USAID's internal design process.

23) Is USAID required to incorporate or act on the information submitted in response to the RFI?

No. USAID may revise the concept based on what it receives, but it is not required to make changes and is not obligated to issue a NOFO.

24) Who pays the costs associated with preparing and submitting an RFI response?

USAID states that any costs incurred in responding to the RFI are the respondent's responsibility.

25) What happens to the information an organization submits in response to the RFI?

USAID notes that information submitted becomes USAID property. Because of that, respondents are cautioned not to include sensitive or non-shareable information.

26) What is the main reason USAID issued this RFI?

The RFI is an early design consultation and market-sounding step. Its purpose is to collect written feedback to improve the eventual activity structure and requirements before USAID decides whether to publish a formal Notice of Funding Opportunity.

27) What geographic focus is indicated for the planned activity?

The RFI describes improving health outcomes in priority districts and strengthening performance at subnational levels (regional, district, and community). Specific district names are not provided in the information summarized here.

28) How does the planned activity relate to Government of Uganda priorities?

The RFI characterizes the overall effort as a multi-component, district-focused health systems and service delivery activity intended to advance Government of Uganda health policy objectives while building durable local leadership and resilience.

Browse more opportunities from the same agency: Uganda USAID-Kampala

Browse more opportunities from the same category: Health

Next opportunity: National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed)

Previous opportunity: Quantum-Enabled Bioimaging and Sensing Approaches for Bioenergy

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFI 720617 22 002

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFI 720617 22 002) also looked into and applied for these:

Funding Opportunity
NIH-DOD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) Apply for RFA AT 22 006

Funding Number: RFA AT 22 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required) Apply for RFA RM 22 002

Funding Number: RFA RM 22 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
PROPEL Health: Promoting Results and Outcomes through Policy and Economic Leavers Apply for 7200AA22APS00002 01

Funding Number: 7200AA22APS00002 01
Agency: Agency for International Development
Category: Health
Funding Amount: $100,000,000
Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed) Apply for RFA OD 22 002

Funding Number: RFA OD 22 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed) Apply for RFA AG 23 003

Funding Number: RFA AG 23 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional) Apply for PAR 22 077

Funding Number: PAR 22 077
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) Apply for PAR 22 093

Funding Number: PAR 22 093
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) Apply for PAR 22 094

Funding Number: PAR 22 094
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) Apply for RFA MH 22 135

Funding Number: RFA MH 22 135
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) Apply for RFA MH 22 136

Funding Number: RFA MH 22 136
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional) Apply for RFA AI 21 079

Funding Number: RFA AI 21 079
Agency: National Institutes of Health
Category: Health
Funding Amount: $900,000
Lipids in Brain Aging and Alzheimer's Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 009

Funding Number: RFA AG 23 009
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 22 088

Funding Number: PAR 22 088
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Development and Renovation of Housing, Breeding, and Research Spaces for Existing NIH-supported NHP Colonies (C06 Clinical Trial Not Allowed) Apply for PAR 21 363

Funding Number: PAR 21 363
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) Apply for RFA MD 22 003

Funding Number: RFA MD 22 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required) Apply for RFA AG 23 008

Funding Number: RFA AG 23 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) (U24 Clinical Trial Optional) Apply for RFA AG 23 006

Funding Number: RFA AG 23 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $425,000
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 032

Funding Number: RFA NS 22 032
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed) Apply for RFA NS 22 033

Funding Number: RFA NS 22 033
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional) Apply for RFA HL 23 003

Funding Number: RFA HL 23 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFI 720617 22 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: